CHF 978.56
(0.57%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 112.77 Million CHF | -27.94% |
2022 | 156.49 Million CHF | 63.69% |
2021 | 95.6 Million CHF | 57.06% |
2020 | 60.86 Million CHF | 14.53% |
2019 | 53.14 Million CHF | -5.62% |
2018 | 56.31 Million CHF | 41.72% |
2017 | 39.73 Million CHF | 42.38% |
2016 | 27.9 Million CHF | -28.63% |
2015 | 39.1 Million CHF | 1.41% |
2014 | 38.55 Million CHF | -28.4% |
2013 | 53.85 Million CHF | 158.06% |
2012 | 20.86 Million CHF | 117.4% |
2011 | 9.59 Million CHF | 159.1% |
2010 | -16.24 Million CHF | 53.94% |
2009 | -35.26 Million CHF | 52.88% |
2008 | -74.83 Million CHF | -250.54% |
2007 | 49.71 Million CHF | 53.46% |
2006 | 32.39 Million CHF | -11.34% |
2005 | 36.53 Million CHF | 122.86% |
2004 | 16.39 Million CHF | -69.39% |
2003 | 53.55 Million CHF | -4.71% |
2002 | 56.19 Million CHF | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 71.38 Million CHF | 0.0% |
2023 Q2 | 55.21 Million CHF | 0.0% |
2023 FY | 112.77 Million CHF | -27.94% |
2023 Q4 | 57.55 Million CHF | 0.0% |
2022 Q2 | 62.74 Million CHF | 0.0% |
2022 Q4 | 93.74 Million CHF | 0.0% |
2022 FY | 156.49 Million CHF | 63.69% |
2021 Q4 | 66.3 Million CHF | 0.0% |
2021 Q2 | 29.29 Million CHF | 0.0% |
2021 FY | 95.6 Million CHF | 57.06% |
2020 Q2 | 20.66 Million CHF | 0.0% |
2020 FY | 60.86 Million CHF | 14.53% |
2020 Q4 | 40.2 Million CHF | 0.0% |
2019 Q4 | 22.18 Million CHF | 0.0% |
2019 FY | 53.14 Million CHF | -5.62% |
2019 Q2 | 30.96 Million CHF | 0.0% |
2018 FY | 56.31 Million CHF | 41.72% |
2018 Q2 | 29.33 Million CHF | 0.0% |
2018 Q4 | 26.97 Million CHF | 0.0% |
2017 Q4 | 19.17 Million CHF | 0.0% |
2017 Q2 | 21.64 Million CHF | 0.0% |
2017 FY | 39.73 Million CHF | 42.38% |
2016 Q4 | 13.94 Million CHF | 0.0% |
2016 FY | 27.9 Million CHF | -28.63% |
2016 Q2 | 13.95 Million CHF | 0.0% |
2015 Q4 | 19.03 Million CHF | 0.0% |
2015 Q2 | 20.06 Million CHF | 0.0% |
2015 FY | 39.1 Million CHF | 1.41% |
2014 Q2 | 18.8 Million CHF | 0.0% |
2014 FY | 38.55 Million CHF | -28.4% |
2014 Q4 | 19.75 Million CHF | 0.0% |
2013 FY | 53.85 Million CHF | 158.06% |
2013 Q4 | 35.32 Million CHF | 0.0% |
2013 Q2 | 18.52 Million CHF | 0.0% |
2012 FY | 20.86 Million CHF | 117.4% |
2012 Q4 | 13.46 Million CHF | 158.06% |
2012 Q3 | 5.21 Million CHF | 0.0% |
2012 Q2 | 5.21 Million CHF | 0.0% |
2012 Q1 | 5.21 Million CHF | 0.0% |
2011 Q3 | 2.39 Million CHF | 0.0% |
2011 Q2 | 2.39 Million CHF | 0.0% |
2011 Q1 | 2.39 Million CHF | 0.0% |
2011 FY | 9.59 Million CHF | 159.1% |
2011 Q4 | 5.21 Million CHF | 117.4% |
2010 FY | -16.24 Million CHF | 53.94% |
2010 Q4 | 2.39 Million CHF | 326.44% |
2010 Q3 | -1.05 Million CHF | 0.0% |
2010 Q2 | -1.05 Million CHF | 0.0% |
2010 Q1 | -1.05 Million CHF | 0.0% |
2009 Q2 | -8.81 Million CHF | 0.0% |
2009 Q4 | -1.05 Million CHF | 87.98% |
2009 FY | -35.26 Million CHF | 52.88% |
2009 Q3 | -8.81 Million CHF | 0.0% |
2009 Q1 | -8.81 Million CHF | 0.0% |
2008 Q2 | -18.7 Million CHF | 0.0% |
2008 Q4 | -8.81 Million CHF | 52.88% |
2008 FY | -74.83 Million CHF | -250.54% |
2008 Q3 | -18.7 Million CHF | 0.0% |
2008 Q1 | -18.7 Million CHF | 0.0% |
2007 Q3 | 5.58 Million CHF | 0.0% |
2007 FY | 49.71 Million CHF | 53.46% |
2007 Q4 | -18.7 Million CHF | -434.8% |
2007 Q2 | 5.58 Million CHF | 0.0% |
2007 Q1 | 5.58 Million CHF | 0.0% |
2006 Q2 | 5.59 Million CHF | 0.0% |
2006 Q1 | 5.59 Million CHF | 0.0% |
2006 FY | 32.39 Million CHF | -11.34% |
2006 Q4 | 5.58 Million CHF | -0.07% |
2006 Q3 | 5.59 Million CHF | 0.0% |
2005 FY | 36.53 Million CHF | 122.86% |
2005 Q4 | 5.59 Million CHF | -38.77% |
2005 Q2 | 9.13 Million CHF | 0.0% |
2005 Q1 | 9.13 Million CHF | 0.0% |
2005 Q3 | 9.13 Million CHF | 0.0% |
2004 FY | 16.39 Million CHF | -69.39% |
2004 Q1 | 4.09 Million CHF | 0.0% |
2004 Q2 | 4.09 Million CHF | 0.0% |
2004 Q3 | 4.09 Million CHF | 0.0% |
2004 Q4 | 9.13 Million CHF | 122.86% |
2003 Q3 | 13.38 Million CHF | 0.0% |
2003 Q2 | 13.38 Million CHF | 0.0% |
2003 FY | 53.55 Million CHF | -4.71% |
2003 Q4 | 4.09 Million CHF | -69.39% |
2003 Q1 | 13.38 Million CHF | 0.0% |
2002 Q1 | 14.04 Million CHF | 0.0% |
2002 Q2 | 14.04 Million CHF | 0.0% |
2002 FY | 56.19 Million CHF | 0.0% |
2002 Q3 | 14.04 Million CHF | 0.0% |
2002 Q4 | 13.38 Million CHF | -4.71% |
2001 Q4 | 14.04 Million CHF | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Relief Therapeutics Holding AG | -98.18 Million CHF | 214.863% |
Tecan Group AG | 132.07 Million CHF | 14.614% |
Santhera Pharmaceuticals Holding AG | 54.78 Million CHF | -105.86% |
Basilea Pharmaceutica AG | 10.45 Million CHF | -979.074% |
Bachem Holding AG | 111.85 Million CHF | -0.818% |
Molecular Partners AG | -61.98 Million CHF | 281.941% |